Year-ender 2024: Pharma takes pole position for 2025 race with 39% index returns, 9 multibaggers. Which stocks to buy?
[hfe_template id='11223']
[ad_1]
Pharma sector is expected to end as the top performer of 2024, closely followed by realty while the third spot could be occupied by consumer durables. Eight other sectors have delivered double-digit returns, outperforming the BSE Sensex on the year-to-date basis while energy, FMCG, banking and manufacturing have turned out to be market laggards.The BSE Healthcare’s 2024 returns as on December 23, Monday stood at 39% with 9 stocks delivering multibagger returns between 207% and 100% viz. Wockhardt, Indraprastha Medical Corporation, Neuland Laboratories, Vimta Labs, Shilpa Medicare, Orchid Pharma, Supriya Lifescience, Windlas Biotech and Solara Active Pharma. BSE Realty’s 35% returns are on the back of solid performances by stocks like Anant Raj, Sobha, Oberoi Realty, Prestige Estates and Godrej Properties which have given returns between 178% and 44%. Consumer durables, consumer discretionary, capital goods, power, information technolog...